Advertisement
Research Article

BRCAness Profile of Sporadic Ovarian Cancer Predicts Disease Recurrence

  • Weiya Z. Wysham,

    Affiliations: Department of Obstetrics and Gynecology, Oregon Health & Science University, Portland, Oregon, United States of America, Knight Cancer Institute, Portland, Oregon, United States of America

    X
  • Paulette Mhawech-Fauceglia,

    Affiliation: Department of Pathology, Roswell Park Cancer Institute, Buffalo, New York, United States of America

    X
  • Hong Li,

    Affiliation: Department of Biostatistics, Oregon Health & Science University, Knight Cancer Institute, Portland, Oregon, United States of America

    X
  • Laura Hays,

    Affiliation: Knight Cancer Institute, Portland, Oregon, United States of America

    X
  • Suzanna Syriac,

    Affiliation: Department of Pathology, Roswell Park Cancer Institute, Buffalo, New York, United States of America

    X
  • Tijana Skrepnik,

    Affiliation: University of Arizona, Tucson, Arizona, United States of America

    X
  • Jay Wright,

    Affiliation: Department of Obstetrics and Gynecology, Oregon Health & Science University, Portland, Oregon, United States of America

    X
  • Nupur Pande,

    Affiliations: Department of Obstetrics and Gynecology, Oregon Health & Science University, Portland, Oregon, United States of America, Knight Cancer Institute, Portland, Oregon, United States of America

    X
  • Maureen Hoatlin,

    Affiliations: Knight Cancer Institute, Portland, Oregon, United States of America, Department of Biochemistry and Molecular Biology, Oregon Health & Science University, Portland, Oregon, United States of America

    X
  • Tanja Pejovic mail

    pejovict@ohsu.edu

    Affiliations: Department of Obstetrics and Gynecology, Oregon Health & Science University, Portland, Oregon, United States of America, Knight Cancer Institute, Portland, Oregon, United States of America

    X
  • Published: January 11, 2012
  • DOI: 10.1371/journal.pone.0030042

Reader Comments (4)

Post a new comment on this article

advanced stage III-IV

Posted by cecilelepage on 18 Jan 2012 at 20:42 GMT

advanced stage III–IV and grade 3 ovarian cancer
http://plosone.org/article/info:doi/10.1371/journal.pone.0030042#article1.front1.article-meta1.abstract1.sec3.p1

As seen in Table 2, the cohort of 186 patients contains 10 patienst with early stage I and II disease and 25 patients with grade 1 and 2 tumors.

No competing interests declared.